Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Coastal Acquisition II A | ACAB | Nov 27, 2024 | 5.77 | 0.00 |
Atlantic Union Bank | AUB | Nov 27, 2024 | 42.24 | -0.78 |
Atlantic Union Bankshares A Pref | AUB-A | Nov 27, 2024 | 25.06 | +1.03 |
Atlantica Sustainable Infrastructure | AY | Nov 27, 2024 | 22.16 | +0.09 |
Atlanticus | ATLC | Nov 27, 2024 | 58.73 | +2.64 |
Atlanticus B Pref | ATLCP | Nov 27, 2024 | 24.08 | +1.00 |
Atlas Energy Solutions | AESI | Nov 27, 2024 | 23.42 | -0.55 |
Atlas Lithium | ATLX | Nov 27, 2024 | 7.14 | +5.62 |
Atlas Pref D | ATCO-D | Nov 27, 2024 | 25.00 | +0.28 |
Atlas Pref H | ATCO-H | Nov 27, 2024 | 24.90 | -0.64 |
AtlasClear Holdings | ATCH | Nov 27, 2024 | 0.20 | 0.00 |
Atlassian A | TEAM | Nov 27, 2024 | 262.46 | +0.09 |
Atmos Energy | ATO | Nov 27, 2024 | 151.43 | +0.73 |
Atmus Filtration Technologies | ATMU | Nov 27, 2024 | 43.06 | -1.51 |
ATN International | ATNI | Nov 27, 2024 | 20.18 | +2.23 |
Atomera | ATOM | Nov 27, 2024 | 5.84 | -5.04 |
Atossa Therapeutics | ATOS | Nov 27, 2024 | 1.28 | -0.78 |
Atour Lifestyle ADR | ATAT | Nov 27, 2024 | 24.83 | -0.68 |
ATRenew A ADR | RERE | Nov 27, 2024 | 3.44 | +10.26 |
AtriCure | ATRC | Nov 27, 2024 | 36.17 | +1.06 |
ATS Corporation | ATS | Nov 27, 2024 | 30.99 | +2.89 |
aTyr Pharma | ATYR | Nov 27, 2024 | 3.44 | +4.56 |
Auburn National Bank | AUBN | Nov 27, 2024 | 23.60 | -0.25 |
Auddia | AUUD | Nov 27, 2024 | 0.55 | +0.15 |
AudioCodes | AUDC | Nov 27, 2024 | 9.10 | -2.47 |
AudioEye | AEYE | Nov 27, 2024 | 26.80 | +1.94 |
Auna S.A.A | AUNA | Nov 27, 2024 | 7.21 | -3.99 |
Aura Biosciences | AURA | Nov 27, 2024 | 9.00 | +0.45 |
Aura FAT Projects Acquisition A | AFAR | Nov 27, 2024 | 11.68 | 0.00 |
Aurinia Pharmaceuticals | AUPH | Nov 27, 2024 | 8.85 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.